Congressional Cannabis Caucus leader OK with hemp ban (Newsletter: June 9, 2025)

*Congresswoman talks medical marijuana for cancer; GOP rep “excited” to
work on psychedelics w Trump admin; DEA psilocybin letter; NH marijuana
bill*

Subscribe to receive Marijuana Moment’s newsletter in your inbox every
weekday morning. It’s the best way to make sure you know which cannabis
stories are shaping the day.
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

*Your support makes Marijuana Moment possible…*

*Hold on, just one second before you read today’s news. *Have you thought
about giving some financial support to Marijuana Moment? If so, today would
be a great day to contribute. We’re planning our reporting for the coming
months and it would really help to know what kind of support we can count
on.

Check us out on Patreon and sign up to give $25/month today:
https://www.patreon.com/marijuanamoment

*/ TOP THINGS TO KNOW*

Congressional Cannabis Caucus co-chair Rep. Dave Joyce (R-OH) and House
Agriculture Committee Chairman Glen Thompson (R-PA) defended legislation to
ban most consumable hemp products, saying that companies are exploiting
current law to sell intoxicants.

Rep. Ashley Hinson (R-IA) spoke about how using medical cannabis helped her
aunt treat cancer symptoms and “allowed her to be able to eat and stay
alive long enough to fight as long as she did”—but added that she’s
concerned about “free-for-alls around marijuana” with broader legalization.

Rep. Dan Crenshaw (R-TX) said he’s “excited” to work with the Trump
administration to advance psychedelics reform, expressing enthusiasm about
federal health officials who appear “friendlier” to the issue compared to
those who served under past presidents.

Attorneys for a doctor seeking to reschedule psilocybin so he can
administer it to terminally ill patients are demanding an update from the
Drug Enforcement Administration on its prior commitment to submit a request
for a scientific review of the psychedelic from the U.S. Department of
Health and Human Services.

The New Hampshire Senate rejected a House bill to decriminalize psilocybin,
but the House advanced a backup plan to more incrementally lower penalties
for the psychedelic as well as separate legislation to legalize home
cultivation of medical cannabis.

Missouri Division of Cannabis Regulation officials will begin conducting
unannounced visits to marijuana dispensaries to collect products for
verification testing on July 1.

Texas lawmakers this session passed legislation to expand medical marijuana
access, ban hemp products and support psychedelics research—while harm
reduction legislation to combat drug overdoses stalled.

Massachusetts marijuana business owners argue in a new op-ed that a pending
bill to raise the license ownership cap and change other rules is a rare
example of “a policy that actually reflects the realities of running a
cannabis business in today’s market.”

Lovewell Farms’s Mike Simpson argues in a new op-ed that pending Rhode
Island bills to restrict hemp-derived THC beverages “misrepresent both the
science behind these products and the legal infrastructure already in
place.”

*/ FEDERAL*

Former White House Chief Strategist Steve Bannon said that reported drug
use by former Department of Government Efficiency head Elon Musk should be
investigated amid his feud with President Donald Trump.

Rep. Jason Crow (D-CO) said psychedelic therapy is “very promising, but we
need good data.”

Former Sen. Kyrsten Sinema (I-AZ) discussed her support for psychedelics
reform.

*/ STATES*

Louisiana Gov. Jeff Landry (R) signed a kratom criminalization bill into
law.

Nebraska Gov. Jim Pillen (R) reportedly caused a vacancy on the Liquor
Control Commission because he wanted someone with more “cannabis
experience” in the role.

A former Maine representative reportedly helped several Chinese nationals
establish marijuana cultivation operations.

A Massachusetts judge denied the state treasurer’s effort to keep records
related to her firing of the top marijuana regulator secret.

Rhode Island regulators designated disproportionately impacted areas for
the purposes of marijuana social equity business applicant eligibility.

Washington State regulators are considering rules concerning acceptable
forms of identification for age verification for purchase of marijuana and
alcohol.

Ohio regulators published guidance on child-resistant packaging for
marijuana products.

An Oregon regulator spokesperson said they are not aware of any
legislature-directed funds to support the psilocybin services program for
2025-27, so officials “must evaluate the possibility of increasing
licensing fees.”

The Pennsylvania Department of Drug and Alcohol Programs is accepting
proposals on “cannabis/recreational marijuana” and other topics for an
Emerging Drug Trends Symposium it is hosting in November.

Minnesota regulators sent a newsletter with updates on various cannabis
compliance issues.


*— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug
policy bills in state legislatures and Congress this year. Patreon
supporters pledging at least $25/month get access to our interactive maps,
charts and hearing calendar so they don’t miss any developments.*


*Learn more about our marijuana bill tracker and become a supporter on
Patreon to get access. —*

*/ LOCAL*

Officials from several Ohio municipalities are pushing state lawmakers not
to divert marijuana revenue away from localities.

*/ INTERNATIONAL*

A German court ruled that prisoners are allowed to possess up to 50 grams
of cannabis in their cells while serving their sentences.

*/ SCIENCE & HEALTH*

A study concluded that the “multifaceted effects of CBD, ranging from
molecular-level modulation to behavioral improvements, underscore its
potential as a comprehensive therapeutic approach for” Alzheimer’s disease.

A study of rats found that “full-spectrum Cannabis sativa extract enhances
gut-peripheral organ integrity after experimental ischemic stroke.”

*/ ADVOCACY, OPINION & ANALYSIS*

A former Arkansas Democratic Party chair is taking on an ownership stake in
a medical cannabis dispensary.

The Fort Worth Star-Telegram editorial board criticized the Texas
lieutenant governor’s push to criminalize consumable hemp products with any
amount of THC.

*/ BUSINESS*

Vireo Growth Inc. closed its acquisition of Proper Brands through the
acquisition of NGH Investments, Inc. and Proper Holdings Management, Inc.

AYR Wellness Inc. received a failure to file cease trade order from
Canadian officials.

Mindbloom, Inc. is suing Dow Jones & Company, Inc. over a Wall Street
Journal article about actor Matthew Perry’s death after taking ketamine
that allegedly libeled the company.

*Make sure to subscribe to get Marijuana Moment’s daily dispatch in your
inbox.*
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

*Photo courtesy of Chris Wallis // Side Pocket Images.*

The post Congressional Cannabis Caucus leader OK with hemp ban (Newsletter:
June 9, 2025) appeared first on Marijuana Moment.